Arndt Vogel: Immune Checkpoint Inhibitors for Child-Pugh B HCC: comprehensive summary of 22 studies with 699 patients.
Quoting Arndt Vogel on X/Twitter:
“Hot off the press: Immune Checkpoint Inhibitors for CP B HCC: Systematic Review & Meta-Analysis in JAMA Oncology
We provide comprehensive summary: 22 studies/699 pts
Data support use of ICI in CP B, but we need prospective data“
For the article click here:
Source: Arndt Vogel/Twitter
Arndt Vogel is a managing senior consultant and professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School. He is the Head of the GI-Cancer Center and of the Center for Personalized Medicine at Medical School Hannover and chairs the Hepatobiliary Cancer Study Group of the AIO, a collaborative group in clinical oncology in Germany. His scientific focus is translational and clinical research in gastrointestinal cancer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023